Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly EBT of -$949000.0 in Q4 2025, down 29.82% quarter-over-quarter from -$731000.0 in Q3 2025, and down 3.26% on a YoY basis from -$981024.7 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' EBT history runs 16 years deep, the most recent figure standing at -$949000.0 for Q4 2025.
- In Q4 2025, EBT fell 3.26% year-over-year to -$949000.0; the TTM figure through Dec 2025 stood at -$3.4 million (up 7.7% YoY), while the FY2025 annual figure was -$2.9 million, up 42.22% from the prior year.
- EBT was -$949000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from -$731000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of -$95000.0 in Q3 2021 to a low of -$3.3 million in Q1 2022.
- Historically, EBT has averaged -$1.2 million across 5 years, with a median of -$973000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: EBT plunged 865.26% in 2022, then surged 64.33% in 2024.
- A 5-year view of EBT shows it stood at -$944000.0 in 2021, then tumbled by 101.8% to -$1.9 million in 2022, then jumped by 51.55% to -$923000.0 in 2023, then increased by 0.43% to -$919000.0 in 2024, then dropped by 3.26% to -$949000.0 in 2025.
- The last three EBT figures came in at -$949000.0 (Q4 2025), -$731000.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -949,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -949,000.00 |
| Sep 30, 2025 | -731,000.00 |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -528,000.00 |
| Dec 31, 2024 | -919,000.00 |
| Sep 30, 2024 | -463,000.00 |
| Jun 30, 2024 | -997,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | -923,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -1.44 Mn |
| Dec 31, 2022 | -1.91 Mn |
| Sep 30, 2022 | -917,000.00 |
| Jun 30, 2022 | -922,000.00 |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -944,000.00 |
| Sep 30, 2021 | -95,000.00 |
| Jun 30, 2021 | -1.10 Mn |
| Mar 31, 2021 | -2.81 Mn |